当前肝移植供体分配系统的局限性与新适应症的影响
本文为综述,聚焦失代偿期肝硬化及慢加急性肝衰竭患者的肝移植问题,指出供体分配优化、等待名单优先排序及移植前后生存方面仍存在认知缺口,并强调需解决严重酒精性肝炎与非酒精性脂肪性肝炎患者移植可及性不平等、性别与地区差异及边缘供体使用等争议。
要点
- 肝移植可挽救失代偿期肝硬化患者生命,但分配系统在优先排序与生存优化上仍有不足
- 慢加急性肝衰竭死亡风险更高,移植前后生存优化策略尚不明确
- 严重酒精性肝炎与非酒精性脂肪性肝炎患者移植可及性不平等亟待解决
核心结论
- 肝移植对失代偿期肝硬化及慢加急性肝衰竭患者具有挽救生命的作用,但供体分配系统在优先排序与生存优化方面仍存在认知缺口。
- 严重酒精性肝炎与非酒精性脂肪性肝炎患者移植可及性不平等、性别与地区差异及边缘供体使用等争议仍需解决。
研究设计与样本
- 综述,旨在对肝移植在失代偿期肝硬化患者中的作用提供批判性视角,并讨论持续存在的不确定性领域。
主要发现
- 失代偿期肝硬化等待名单死亡风险高,快速失代偿伴肝外器官衰竭即为慢加急性肝衰竭,死亡风险更高但移植可显著改善生存。
- 对慢加急性肝衰竭患者移植前及移植后优先排序与器官分配优化及生存改善的理解仍存在缺口。
- 严重酒精性肝炎与非酒精性脂肪性肝炎患者肝移植可及性不平等亟待解决。
- 性别与地区差异以及边缘供体使用仍存在争议。
临床怎么用
- 临床应关注失代偿期肝硬化及慢加急性肝衰竭患者的移植评估与优先排序,并重视酒精性肝炎与脂肪性肝炎患者的移植可及性公平问题。
局限性
- 本文为综述,未提供原始研究数据或定量合并结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Liver transplantation represents a life-saving treatment for patients with decompensated cirrhosis, a severe condition associated with a high risk of waiting list mortality. When decompensation occurs rapidly in the presence of extrahepatic organ failures, the condition is called acute-on-chronic liver failure, which is associated with an even higher risk of death, though liver transplantation can also markedly improve survival in affected patients. However, there are still gaps in our understanding of how to optimise prioritisation and organ allocation, as well as survival among patients with acute-on-chronic liver failure (both before and after transplant). Moreover, it is urgent to address inequalities in access to liver transplantation in patients with severe alcoholic hepatitis and non-alcoholic steatohepatitis. Several controversies still exist regarding gender and regional disparities, as well as the use of suboptimal donor grafts. In this review, we aim to provide a critical perspective on the role of liver transplantation in patients with decompensated cirrhosis and address areas of ongoing uncertainty.
引用
- Burra P, Samuel D, Sundaram V, et al. Limitations of current liver donor allocation systems and the impact of newer indications for liver transplantation. J Hepatol. 2021. PMID: 34039488. doi:10.1016/j.jhep.2021.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。